SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $120,000 | -98.9% | 10,000 | -98.8% | 0.00% | -98.7% |
| Q1 2021 | $10,756,000 | +6794.9% | 858,429 | +8484.3% | 0.24% | +5825.0% |
| Q4 2020 | $156,000 | +66.0% | 10,000 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $94,000 | +4.4% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $90,000 | +40.6% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $64,000 | -23.8% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $84,000 | -7.7% | 10,000 | 0.0% | 0.00% | -25.0% |
| Q3 2019 | $91,000 | -15.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $108,000 | +13.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $95,000 | -17.4% | 10,000 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $115,000 | -32.0% | 10,000 | 0.0% | 0.01% | -16.7% |
| Q3 2018 | $169,000 | +19.0% | 10,000 | 0.0% | 0.01% | +20.0% |
| Q2 2018 | $142,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |